Retraction Note: OCT4 as a target of miR-34a stimulates p63 but inhibits p53 to promote human cell transformation

Affiliations

• ¹ Department of Radiation Oncology, Emory University School of Medicine, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
• ² Division of Space Life Sciences, Universities Space Research Association, Houston, TX, USA.
• ³ Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX, USA.
• ⁴ Department of Cell Biology, UT Southwestern Medical Center, Dallas, TX, USA.
• ⁵ Department of Hematology and Oncology, Emory University School of Medicine, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
• ⁶ Department of Medical Molecular Biology, Beijing Institute of Biotechnology, Beijing, China.
• ⁷ Department of Health Physics and Diagnostic Sciences, University of Nevada, Las Vegas, NV, USA. Francis.Cucinotta@unlv.edu.
• ⁸ Department of Radiation Oncology, Emory University School of Medicine, Winship Cancer Institute of Emory University, Atlanta, GA, USA. ywang94@emory.edu.